Understanding the Risk of Falls in People with Parkinson’s Disease

Dr Joana Caetano, Dr Jasmine Menant and Prof Stephen Lord.   Balance and walking impairments are disabling symptoms of Parkinson’s disease that adversely affect performance of daily activities, reduce independence and increase the risk of falls. Around 60% of people with Parkinson’s disease fall at least once a year, with a large proportion (50-86%) falling multiple times in this period. […]

Read more

Exercise for chronic musculoskeletal pain: A biopsychosocial approach

Chronic musculoskeletal pain (CMP) is a common condition affecting 1 in 5 adults worldwide. CMP encompasses a diverse range of conditions such as osteoarthritis, chronic low back pain (CLBP), fibromyalgia and chronic widespread pain, where ongoing pain is felt in the bones, joints and tissues. Exercise is considered to be the primary treatment intervention for people with CMP; it is […]

Read more

Prof Kaarin Anstey to lead an innovative national research agenda on ageing and dementia

Professor Kaarin Anstey joins NeuRA in January 2018 to lead an innovative multi-disciplinary team addressing ageing research, with a focus on vital community lifestyle solutions around dementia in the Australian community. Speaking about her new appointment, Prof Anstey said, “I’m looking forward to expanding my research programs on the epidemiology of cognition and dementia with a focus on identifying lifestyle, […]

Read more

Chronic Mental Health Issues with Ageing and HIV

By Dr Lucette Cysique  News relating to HIV infection in Australia are full of success stories particularly since the reduction of HIV infection rate with the ramping up of pre-exposure prophylaxis (PrEP), principally in metropolitan bisexual and gay men (BGM), however, with an ageing HIV population, there remain key challenges such as, getting older with HIV, and greater risk of […]

Read more

New Discovery in MND sparks hope

By Prof Lars Ittner Senior Principal Research Scientist, Professor Lars Ittner is working to understand Motor Neurone Disease (MND), and trying to develop novel therapeutic approaches for this devastating condition. Specifically, Prof Ittner develops disease models that allow his team to understand the detailed cellular events that lead to the dysfunction and death of neurons and therefore to the loss […]

Read more

Unlocking the Genetic Code of Bipolar Disorder

In Australia alone, 250,000 people are affected by bipolar disorder. Current treatments are highly variable for the severe and debilitating psychiatric condition and the specific genetic causes have remained largely obscure. Bipolar disorder is most commonly treated with lithium, but this is only effective for 30% of patients. Unlocking the genetic code of bipolar disorder and using pharmacogenomics studies to […]

Read more
1 2 3 4 24